# A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus

> **NCT00002287** · NA · COMPLETED · sponsor: **Glaxo Wellcome**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00002287
- **Lead sponsor:** Glaxo Wellcome
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002287, "A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*